Dr. Christopher M. Godell, MD

Dr. Godell practices at Austin Endoscopy Center Leander in Leander, Texas.

Dr. Godell's NPI, 1164407615, was assigned on December 7, 2005. Dr. Godell graduated from UTMB Health in 1999. Dr. Godell holds Texas license M1113.

Dr. Godell's primary practice is Austin Endoscopy Center Leander, at 1361 Hero Way Suite 100, Leander, TX 78641.

Dr. Godell's primary practice is Austin Endoscopy Center Leander in Leander, Texas. Dr. Godell is also affiliated with St. David's Medical Center. The medical group on file is Austin Gastroenterology. Dmand AI also links Dr. Godell to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Godell practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Godell's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Godell is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Godell's licenses on file in 2 states: Texas and Ohio.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver and gastroduodenitis among the conditions Dr. Godell treats.

CMS data shows 717 Medicare services from Dr. Godell across 10 procedure codes in 2024, for 382 Medicare patients. Medicare paid $67,031 for them.

CMS counts 382 Medicare patients who saw Dr. Godell in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Godell's median patient age at 60, with 53% women.

In 2024, Dr. Godell wrote 1,141 Medicare Part D claims for 353 patients. 82% of them were for generic drugs. CMS names the drug for 961 of them, across 23 drugs with 11 or more claims each, at $136,825 in total drug cost. In 2023, CMS named 764 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Godell for performance year 2024, reported as part of a group. Dr. Godell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Godell as offering telehealth. CMS counts 234 procedures of colonoscopy by Dr. Godell, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Godell. The most frequent topics are Astacoidea, Axons and Cell Membrane. Dr. Godell has published most often in Proc Natl Acad Sci U S A. Dr. Godell's most frequent co-author is Christopher S. Eddleman, MD, PhD.

CMS Open Payments shows 585 general payments to Dr. Godell from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $3,612.

Dr. Godell graduated from UTMB Health in 1999.

Dr. Godell is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.